Test Entry - Detail

Myositis Autoantibody


General
  Clinical Use: For evaluation of patients with suspected idiopathic inflammatory myopathy (including the clinical subtypes of dermatomyositis, overlap myositis and anti-synthetase syndrome, polymyositis and SRP-related immune mediated necrotising myositis).
The panel assesses for antibodies to Ro52, Jo1, OJ, EJ, PL-7, PL-12, PM-Scl75, PM-Scl100, Ku, SAE, TIF1-gamma, MDA5, NXP2, Mi2a, Mi2b and SRP.
Note, this panel does not include antibodies to HMGCR (used for evaluation of HMGCR antibody associated immune mediated necrotising myositis) or CN1a antibodies (used for evaluation of inclusion body myositis).
These antibody tests must be requested separately.
  Availability:
  Aliases/Synonyms: Anti-PM-Scl Autoantobody,   Anti-Synthetase Autoantibody,   EJ Autoantibody,   Ku Autoantibody,   MDA5 Autoantibody,   Mi-2 Autoantibody,   NXP2 Autoantibody,   OJ Autoantibody,   PL-12 Autoantibody,   PL-7 Autoantibody,   PMSCL Autoantibody,   SAE1 Autoantibody,   Scleroderma Panel,   SRP Autoantibody,   TIF1 Autoantibody,  
  Code: MYOS
  Handling Instructions (to laboratory): Send sample chilled.
  Hyperlink:
  Reference Interval:
Refer to report or laboratory


Collection Requirements
  Container: Serum Sep. Tube-SST (GOLD),  
  Sample Type: See container
  Minimum Collection Volume: 1mL
  Collection Instructions:


Processing Requirements
  Alternate Containers:
  Processing Instructions:
  Minimum Assay Volume: 100uL
  Stability: 7 days chilled
  Transport Instructions (to testing laboratory): Send sample chilled.


Testing Locations
  Performed at:
Section Department Site Contact Phone
- Immunology QEII Medical Centre 6383 4306


Last Updated : 12-06-2025 10:15